Precision BioSciences, Inc.DTILNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank94
3Y CAGR+109.4%
5Y CAGR+74.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+109.4%/yr
vs +27.6%/yr prior
5Y CAGR
+74.8%/yr
Recent acceleration
Acceleration
+81.8pp
Accelerating
Percentile
P94
Near historical high
vs 5Y Ago
16.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 160.52% |
| Q3 2025 | 5.53% |
| Q2 2025 | 1.06% |
| Q1 2025 | 11.00% |
| Q4 2024 | -16.78% |
| Q3 2024 | -188.11% |
| Q2 2024 | 676.69% |
| Q1 2024 | 71.88% |
| Q4 2023 | -20.44% |
| Q3 2023 | -295.11% |
| Q2 2023 | 76.57% |
| Q1 2023 | -10.28% |
| Q4 2022 | 17.49% |
| Q3 2022 | 50.42% |
| Q2 2022 | -8.25% |
| Q1 2022 | 11.07% |
| Q4 2021 | -166.42% |
| Q3 2021 | -153.36% |
| Q2 2021 | 215.42% |
| Q1 2021 | 20.18% |
| Q4 2020 | 9.84% |
| Q3 2020 | 20.62% |
| Q2 2020 | -19.32% |
| Q1 2020 | -25.78% |
| Q4 2019 | 0.53% |
| Q3 2019 | 7.93% |
| Q2 2019 | -22.45% |
| Q1 2019 | -21.04% |
| Q4 2018 | -54.16% |
| Q3 2018 | 13.84% |
| Q2 2018 | -31.29% |
| Q1 2018 | 0.00% |